Arndt Vogel, Head of the Center for Personalized Medicine, MHH at Medical University of Hanover, shared a post on X about a paper by Janina Eden published in the JHEP Reports:
“HCC recurrence in liver transplants treated with hypothermic oxygenated machine perfusion: An international matched cohort study․
Hypothermic oxygenated machine perfusion-treated liver transplant reduce risk of HCC reccurrence․
Hope for HCC liver transplant․”
Title: HCC recurrence in liver transplants treated with hypothermic oxygenated machine perfusion: An international matched cohort study
Authors: Janina Eden, Philip Müller, Christoph Kuemmerli, Marco Bongini, Francesca Albanesi, Carlo Sposito, Gabriela Berlakovich, Bettina Buchholz, Florin Botea, Stefania Camagni, Matteo Cescon, Umberto Cillo, Fabio Colli, Philippe Compagnon, Luciano De Carlis, Riccardo De Carlis, Fabrizio Di Benedetto, Jule Dingfelder, Dulce Diogo, Daniele Dondossola, Moritz Drefs, Jiri Fronek, Giuliana Germinario, Enrico Gringeri, Christiano Guidetti, Georg Györi, Matej Kocik, Efrayim Küçükerbil, Dionysios Koliogiannis, Hwai-Ding Lam, Georg Lurje, Paolo Magistri, Diethard Monbaliu, Mostafa el Moumni, Beat Müller, Damiano Patrono, Wojciech Polak, Robert Porte, Matteo Ravaioli, Michel Rayar, Renato Romagnoli, Gustaf Sörensen, Deniz Uluk, Pierre Clavien, Vincenzo Mazzaferro, Philipp Dutkowski, Vincent de Meijer
Read the Full Article.
Other articles featuring Arndt Vogel on OncoDaily.